|
ZFX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.66899876936122E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.02800032112327E-10 |
| Normal-vs-Stage2 |
1.05790000004546E-06 |
| Normal-vs-Stage3 |
8.98170426921752E-14 |
| Normal-vs-Stage4 |
1.64668279012403E-12 |
| Stage1-vs-Stage2 |
3.626800E-01 |
| Stage1-vs-Stage3 |
6.652400E-02 |
| Stage1-vs-Stage4 |
4.46229999999659E-05 |
| Stage2-vs-Stage3 |
4.412100E-02 |
| Stage2-vs-Stage4 |
3.191700E-04 |
| Stage3-vs-Stage4 |
3.797800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.8376969097319E-11 |
| Normal-vs-AfricanAmerican |
8.19310000000906E-05 |
| Normal-vs-Asian |
8.09169997673109E-09 |
| Caucasian-vs-AfricanAmerican |
4.216200E-01 |
| Caucasian-vs-Asian |
6.840400E-01 |
| AfricanAmerican-vs-Asian |
6.547000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.99240000053891E-08 |
| Male-vs-Female |
1.62447832963153E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.22260037836031E-10 |
| Normal-vs-Age(41-60Yrs) |
1.12030051901968E-10 |
| Normal-vs-Age(61-80Yrs) |
2.22954987805224E-12 |
| Normal-vs-Age(81-100Yrs) |
2.229200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.509800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.655410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.974370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.458200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.057400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.709400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.273500E-02 |
| Classical-VS-Follicular |
5.606400E-01 |
| Classical-VS-Other |
1.050610E-01 |
| Classical-VS-Normal |
9.05669983453095E-10 |
| Tall-VS-Follicular |
7.982700E-03 |
| Tall-VS-Other |
5.964600E-01 |
| Tall-VS-Normal |
1.32840405342449E-11 |
| Follicular-VS-Other |
9.921500E-02 |
| Follicular-VS-Normal |
3.87749998775888E-09 |
| Other-VS-Normal |
1.649280E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61599972187321E-10 |
| Normal-vs-N1 |
5.2370996428408E-11 |
| N0-vs-N1 |
1.414770E-01 |
|
|
